Fortress Biotech, Inc. (FBIO)
1.93
-0.06
(-3.02%)
USD |
NASDAQ |
Oct 23, 16:00
1.915
-0.02
(-0.78%)
After-Hours: 20:00
Fortress Biotech Price to Book Value : 0.3917 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.3917 |
| October 22, 2026 | 0.4039 |
| October 21, 2026 | 0.3937 |
| October 20, 2026 | 0.3937 |
| October 19, 2026 | 0.3795 |
| October 16, 2026 | 0.3795 |
| October 15, 2026 | 0.3876 |
| October 14, 2026 | 0.3856 |
| October 13, 2026 | 0.3957 |
| October 12, 2026 | 0.4282 |
| October 09, 2026 | 0.4333 |
| October 08, 2026 | 0.4242 |
| October 07, 2026 | 0.414 |
| October 06, 2026 | 0.416 |
| October 05, 2026 | 0.4242 |
| October 02, 2026 | 0.412 |
| October 01, 2026 | 0.4201 |
| September 30, 2026 | 0.4343 |
| September 29, 2026 | 0.4465 |
| September 28, 2026 | 0.4404 |
| September 25, 2026 | 0.4627 |
| September 24, 2026 | 0.4627 |
| September 23, 2026 | 0.4749 |
| September 22, 2026 | 0.4972 |
| September 21, 2026 | 0.4891 |
| Date | Value |
|---|---|
| September 18, 2026 | 0.5094 |
| September 17, 2026 | 0.5094 |
| September 16, 2026 | 0.4992 |
| September 15, 2026 | 0.5053 |
| September 14, 2026 | 0.5135 |
| September 11, 2026 | 0.5114 |
| September 10, 2026 | 0.5216 |
| September 09, 2026 | 0.5337 |
| September 08, 2026 | 0.55 |
| September 04, 2026 | 0.552 |
| September 03, 2026 | 0.55 |
| September 02, 2026 | 0.554 |
| September 01, 2026 | 0.5439 |
| August 31, 2026 | 0.5551 |
| August 28, 2026 | 0.5622 |
| August 27, 2026 | 0.5682 |
| August 26, 2026 | 0.5703 |
| August 25, 2026 | 0.5743 |
| August 24, 2026 | 0.5946 |
| August 21, 2026 | 0.5825 |
| August 20, 2026 | 0.5622 |
| August 19, 2026 | 0.5784 |
| August 18, 2026 | 0.5906 |
| August 17, 2026 | 0.5723 |
| August 14, 2026 | 0.5946 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Inovio Pharmaceuticals, Inc. | 16.90 |
| Kura Oncology, Inc. | 17.65 |
| Spero Therapeutics, Inc. | 1.460 |
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
Price to Book Value Related Metrics
| PE Ratio | 0.7265 |
| PS Ratio | 0.9491 |
| Price to Free Cash Flow | 0.5402 |
| Price | 1.93 |
| Earnings Yield | 137.6% |
| Market Cap | 64.29M |
| Normalized PE Ratio | 0.7882 |